Quansys Biosciences Q-Plex™ Array Technology Demonstrates Improved Test Time and Reduced Complexity of Aviir MIRISK VP® Cardiac Health Panel
Logan, Utah June 20, 2014, — Quansys Biosciences, a pioneer in multiplex ELISA development and manufacture, is releasing a new 14-plex Pneumococcal Array. Quansys, an ISO 9001 and 13485 registered company, is providing this product for the evaluation and detection of IgG antibody concentrations to 14 pneumococcal polysaccharide (PnPs) serotypes (1, 3, 4, 6B, 7F, 8, 9N, 9V, 12F, 14, a8C, 19A, 19F and 23F). With 14 unique serotypes represented by individual spots in the bottom of a 96 well plate, along with both CPS positive and negative controls, users can in as little as 90 minutes have over 1120 unique data points to analyze. For over 10 years, Quansys continues to provide novel, cost effective solutions.
“As we focus on current health concerns and risks, S. pneumoniae continues to create significant pain and suffering in the lives of millions of people. We are proud to be offering a high quality and cost effective solution for the assessment of the seraprevalance of this disease. We are excited to be launching this product on July 28th 2014 at this year’s annual meeting of the American Association of Clinical Chemistry,” said Matthew Groll, General Manager at Quansys Biosciences.
About Quansys Biosciences Inc.
Quansys Biosciences is dedicated to the development and manufacture of multiplexed assays for protein quantification. Quansys Biosciences Q-Plex Array Technology aids researchers in better understanding of disease. The Q-Plex Technology includes multiplex and singleplex assays built to maximize the quantity and quality of data from biological samples. To support its multiplex assays Quansys also provides the Q-View Imaging system consisting of: Q-View Software, a user friendly software package that enables the acquisition and analysis of large amounts of multiplex data and the Q-View Imager, a high resolution imaging system used to capture chemiluminescent assays. Quansys Biosciences was founded in 2005 as a Spendlove Research Foundation company.
To learn more about how Quansys Biosciences can provide the value of the Q-Plex Technology to your research studies, contact Chris Lyman, the company’s R&D Project Manager at email@example.com or